Autry, AE, Adachi, M, Nosyreva, E, Na, ES, Los, MF, Cheng, PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature
2011; 475: 91–5.
Zanos, P, Moaddel, R, Morris, PJ, Georgiou, P, Fischell, J, Elmer, GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature
2016; 533: 481–6.
McGirr, A, Berlim, MT, Bond, DJ, Fleck, MP, Yatham, LN, Lam, RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med
2015; 45: 693–704.
Xu, Y, Hackett, M, Carter, G, Loo, C, Galvez, V, Glozier, N, et al. Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis. Int J Neuropsychopharmacol
2016; 19: pyv124.
Loo, CK, Galvez, V, O'Keefe, E, Mitchell, PB, Hadzi-Pavlovic, D, Leyden, J, et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr Scand
2016; 134: 48–56.
Polyakova, M, Schroeter, ML, Elzinga, BM, Holiga, S, Schoenknecht, P, de Kloet, ER, et al. Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature. PLoS ONE
2015; 10: e0141564.
McGirr, A, Berlim, MT, Bond, DJ, Neufeld, NH, Chan, PY, Yatham, LN, et al. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. J Psychiatr Res
2015; 62: 23–30.
Homayoun, H, Moghaddam, B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci
2007; 27: 11496–500.
Abdallah, CG, Fasula, M, Kelmendi, B, Sanacora, G, Ostroff, R. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT
2012; 28: 157–61.
Jarventausta, K, Chrapek, W, Kampman, O, Tuohimaa, K, Bjorkqvist, M, Hakkinen, H, et al. Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study. J ECT
2013; 29: 158–61.
Kuscu, OO, Karacaer, F, Biricik, E, Gulec, E, Tamam, L, Gunes, Y. Effect of ketamine, thiopental and ketamine-thiopental combination during electroconvulsive therapy for depression. Turk J Anaesthesiol Reanim
2015; 43: 313–7.
Loo, CK, Katalinic, N, Garfield, JB, Sainsbury, K, Hadzi-Pavlovic, D, MacPherson, R. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. J Affect Disord
2012; 142: 233–40.
Rybakowski, JK, Bodnar, A, Krzywotulski, M, Chlopocka-Wozniak, M, Michalak, M, Rosada-Kurasinska, J, et al. Ketamine anesthesia, efficacy of electroconvulsive therapy, and cognitive functions in treatment-resistant depression. J ECT
2016; 32: 164–8.
Salehi, B, Mohammadbeigi, A, Kamali, AR, Taheri-Nejad, MR, Moshiri, I. Impact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trial. Ann Card Anaesth
2015; 18: 486–90.
Shams Alizadeh, N, Maroufi, A, Nasseri, K, Sadeghi Najafabadi, SH, Mousavi Taghiabad, A, Gharibi, F, et al. Antidepressant effect of combined ketamine and electroconvulsive therapy on patients with major depressive disorder: a randomized trial. Iran J Psychiatry Behav Sci
2015; 9: e1578.
Yoosefi, A, Sepehri, AS, Kargar, M, Akhondzadeh, S, Sadeghi, M, Rafei, A, et al. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study. J ECT
2014; 30: 15–21.
Zhong, X, He, H, Zhang, C, Wang, Z, Jiang, M, Li, Q, et al. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression. J Affect Disord
2016; 201: 124–30.
Anderson, IM, Blamire, A, Branton, T, Brigadoi, S, Clark, R, Downey, D, et al. Randomised-controlled trial of ketamine augmentation of ECT on neuropsychological and clinical outcomes in depression (Ketamine-ECT Study). Efficacy and Mechanism Evaluation, .
Prudic, J, Haskett, RF, Mulsant, B, Malone, KM, Pettinati, HM, Stephens, S, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry
1996; 153: 985–92.